Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Appl Immunohistochem Mol Morphol
7 Bladder Cancer
1 BMC Urol
1 Cancer
1 Cancer Cell Int
2 Cancer Sci
1 Cell Death Dis
1 Clin Genitourin Cancer
1 Cytotherapy
1 Expert Opin Biol Ther
1 Front Endocrinol (Lausanne)
1 Gene
1 Int J Med Sci
2 J Cancer
2 J Clin Oncol
1 J Robot Surg
2 J Urol
1 Medicine (Baltimore)
1 Methods Mol Biol
1 Minerva Urol Nefrol
1 Nat Med
2 Sci Rep
1 Theranostics
1 Urol Oncol
1 Urologe A
1 Urology
1 Vet Comp Oncol

    Appl Immunohistochem Mol Morphol

  1. HANLEY KZ, Cohen C, Osunkoya AO
    Hepatocyte Nuclear Factor-1beta Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall.
    Appl Immunohistochem Mol Morphol. 2017;25:134-138.
    >> Share

    Bladder Cancer

  2. LI R, Sylvester R, Dinney CP, Kamat AM, et al
    Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease.
    Bladder Cancer. 2017;3:147-148.
    >> Share

  3. YANG X, Su LJ, La Rosa FG, Smith EE, et al
    The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model.
    Bladder Cancer. 2017;3:201-210.
    >> Share

  4. KATES M, Chappidi MR, Brant A, Milbar N, et al
    High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.
    Bladder Cancer. 2017;3:191-199.
    >> Share

  5. SUI W, Lim EA, Joel Decastro G, McKiernan JM, et al
    Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy.
    Bladder Cancer. 2017;3:181-189.
    >> Share

  6. BREYER J, Shalekenov S, Aziz A, van Rhijn BWG, et al
    Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer.
    Bladder Cancer. 2017;3:173-180.
    >> Share

  7. KAMAT AM, Lerner S, Black P, Bellmunt J, et al
    Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer.
    Bladder Cancer. 2017;3:145-146.
    >> Share

  8. FLAIG TW, Kamat AM, Hansel D, Ingersoll MA, et al
    Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.
    Bladder Cancer. 2017;3:211-223.
    >> Share

    BMC Urol

  9. REN H, Tang P, Zhao Q, Ren G, et al
    Symptom clusters and related factors in bladder cancer patients three months after radical cystectomy.
    BMC Urol. 2017;17:65.
    >> Share


  10. RIMAR KJ, Tran PT, Matulewicz RS, Hussain M, et al
    The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
    Cancer. 2017;123:1912-1924.
    >> Share

    Cancer Cell Int

  11. LIU J, Duan X
    PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells.
    Cancer Cell Int. 2017;17:76.
    >> Share

    Cancer Sci

  12. MIYAKE M, Morizawa Y, Hori S, Tatsumi Y, et al
    Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
    Cancer Sci. 2017 Aug 24. doi: 10.1111/cas.13384.
    >> Share

  13. YUAN GJ, Chen X, Lu J, Feng ZH, et al
    CBX8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway.
    Cancer Sci. 2017 Aug 24. doi: 10.1111/cas.13383.
    >> Share

    Cell Death Dis

  14. LI J, Xu X, Meng S, Liang Z, et al
    MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
    Cell Death Dis. 2017;8:e3010.
    >> Share

    Clin Genitourin Cancer

  15. HUO J, Chu Y, Chamie K, Smaldone MC, et al
    Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.
    Clin Genitourin Cancer. 2017 Jul 26. pii: S1558-7673(17)30215.
    >> Share


  16. HUANG CP, Chen CC, Shyr CR
    The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer.
    Cytotherapy. 2017 Aug 14. pii: S1465-3249(17)30633.
    >> Share

    Expert Opin Biol Ther

  17. BOEGEMANN M, Aydin AM, Bagrodia A, Krabbe LM, et al
    Prospects and progress of immunotherapy for bladder cancer.
    Expert Opin Biol Ther. 2017 Aug 23:1-15. doi: 10.1080/14712598.2017.1366445.
    >> Share

    Front Endocrinol (Lausanne)

  18. MIRSAIDI N, Burns MP, McClain SA, Forsyth E, et al
    Enhanced Mortality to Metastatic Bladder Cancer Cell Line MB49 in Vasoactive Intestinal Peptide Gene Knockout Mice.
    Front Endocrinol (Lausanne). 2017;8:162.
    >> Share


  19. WU Z, Wang S, Jiang F, Li Q, et al
    Erratum to "Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer" [Gene 626C (2017) 407-413].
    Gene. 2017 Aug 15. pii: S0378-1119(17)30624-8. doi: 10.1016/j.gene.2017.
    >> Share

    Int J Med Sci

  20. PICHLER R, Tulchiner G, Fritz J, Schaefer G, et al
    Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Int J Med Sci. 2017;14:811-819.
    >> Share

    J Cancer

  21. CAO R, Wang G, Qian K, Chen L, et al
    Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARgamma-SIRT1 feedback loop.
    J Cancer. 2017;8:2282-2295.
    >> Share

  22. CHEN W, Luo K, Ke Z, Kuai B, et al
    TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling.
    J Cancer. 2017;8:1892-1899.
    >> Share

    J Clin Oncol

  23. SHORE ND, Boorjian SA, Canter DJ, Ogan K, et al
    Intravesical rAd-IFNalpha/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
    J Clin Oncol. 2017 Aug 23:JCO2017723064. doi: 10.1200/JCO.2017.72.3064.
    >> Share

  24. BALAR AV
    Immune Checkpoint Blockade in Metastatic Urothelial Cancer.
    J Clin Oncol. 2017;35:2109-2112.
    >> Share

    J Robot Surg

  25. DILIZIA EM, Sadeghi F
    Surgical and pathological outcomes of robotic-assisted radical cystectomy for bladder cancer in the community setting.
    J Robot Surg. 2017 Aug 23. doi: 10.1007/s11701-017-0740.
    >> Share

    J Urol

  26. CHANG SS
    Re: New Strategies in Bladder Cancer: A Second Coming for Immunotherapy.
    J Urol. 2017;198:482-483.
    >> Share

  27. CHANG SS
    Re: Prediction Model for Recurrence Probabilities after Intravesical Chemotherapy in Patients with Intermediate-Risk Non-Muscle-Invasive Bladder Cancer, Including External Validation.
    J Urol. 2017;198:482-483.
    >> Share

    Medicine (Baltimore)

  28. YANG Z, Yang X, Lu X, Gao L, et al
    Primary malignant mesenchymoma of bladder: Case report and review of the literature.
    Medicine (Baltimore). 2017;96:e7579.
    >> Share

    Methods Mol Biol

  29. LIANG LG, Sheng YF, Zhou S, Inci F, et al
    An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.
    Methods Mol Biol. 2017;1660:355-364.
    >> Share

    Minerva Urol Nefrol

  30. DAL MORO F, Haber GP, Wiklund P, Canda AE, et al
    Robotic intracorporeal urinary diversion: practical review of current surgical techniques.
    Minerva Urol Nefrol. 2017;69:14-25.
    >> Share

    Nat Med

  31. RICKMAN DS, Beltran H, Demichelis F, Rubin MA, et al
    Biology and evolution of poorly differentiated neuroendocrine tumors.
    Nat Med. 2017;23:1-10.
    >> Share

    Sci Rep

  32. PAN Y, Chang T, Marcq G, Liu C, et al
    In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer.
    Sci Rep. 2017;7:9309.
    >> Share

  33. CHA KH, Hadjiiski L, Chan HP, Weizer AZ, et al
    Bladder Cancer Treatment Response Assessment in CT using Radiomics with Deep-Learning.
    Sci Rep. 2017;7:8738.
    >> Share


  34. ZHUANG J, Shen L, Yang L, Huang X, et al
    TGFbeta1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.
    Theranostics. 2017;7:3053-3067.
    >> Share

    Urol Oncol

  35. MOSSANEN M, Kibel AS, Goldman RH
    Exploring exposure to Agent Orange and increased mortality due to bladder cancer.
    Urol Oncol. 2017 Aug 17. pii: S1078-1439(17)30392.
    >> Share

    Urologe A

  36. AUTENRIETH ME, Horn T, Kurtz F, Nguyen K, et al
    [Intravesical radioimmunotherapy of carcinoma in situ of the urinary bladder after BCG failure].
    Urologe A. 2017;56:40-43.
    >> Share


  37. MARIAPPAN P, Lavin V, Phua CQ, Khan SAA, et al
    Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers - a Prospective Double-Blind Clinical Study.
    Urology. 2017 Aug 14. pii: S0090-4295(17)30802.
    >> Share

    Vet Comp Oncol

  38. GUSTAFSON TL, Kitchell BE, Biller B
    Hedgehog signaling is activated in canine transitional cell carcinoma and contributes to cell proliferation and survival.
    Vet Comp Oncol. 2017;15:174-183.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016